Skip to main content

bleomycin

Generic: BLEOMYCIN SULFATE·Brand: BLENOXANE, BLEOMYCIN SULFATE

bleomycin: 5 clinical trials tracked.

bleomycin evidence translation

What we can confirm

5 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about bleomycin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 3 study sponsors
Clinical Trials (5)

A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma

NCT04685616·Phase 3
Recruiting

Primary endpoint: Progression free survival (PFS)

InterventionalRandomizedopen1,042 targetStarted 2022-04Completion 2032-0950 sites · Australia, Belgium, Canada, Denmark…University College, London

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

NCT03755804·Phase 2·GHRS
Active, not recruiting

Primary endpoint: Response rate of adequate response

Interventionalopen232 targetStarted 2018-12Completion 2028-078 sites · United StatesSt. Jude Children's Research Hospital

An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults With Newly Diagnosed Classical Hodgkin Lymphoma With Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)

NCT03407144·Phase 2·MRK
Active, not recruiting

Primary endpoint: Objective Response Rate (ORR) in SER Participants By Risk Group (Low, High) as Assessed by Blinded Independent Central Review (BICR)

Interventionalopen340 targetStarted 2018-04Completion 2026-1150 sites · Brazil, United StatesMerck Sharp & Dohme LLC

A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors

NCT03067181·Phase 3
Recruiting

Primary endpoint: Overall survival

InterventionalRandomizedopen1,780 targetStarted 2017-05Completion 2027-0650 sites · United StatesChildren's Oncology Group

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

NCT01712490·Phase 3·TAK
Completed

Primary endpoint: Modified Progression-free Survival (mPFS) Per Independent Review Facility (IRF)

InterventionalRandomizedopen1,334 enrolledStarted 2012-11Completion 2026-0250 sites · United StatesTakeda